APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etoricoxib

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Etoricoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchEtoricoxib Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Etoricoxib Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Etoricoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etoricoxib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Etoricoxib Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Etoricoxib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Etoricoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Etoricoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Etoricoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Etoricoxib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Etoricoxib include Shanghai Shyndec Pharmaceutical, Qilu Pharmaceutical, Merck & Co, Easton Biopharmaceuticals, Beijing Tide Pharmaceutical, Morepen Laboratories, Metrochem API, Hema Pharmaceuticals and Frosst Iberica SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Etoricoxib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Etoricoxib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Etoricoxib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Etoricoxib market size, projected growth trends, production technologies, key applications, and end-use industries.

Etoricoxib Segment by Company

Shanghai Shyndec Pharmaceutical

Qilu Pharmaceutical

Merck & Co

Easton Biopharmaceuticals

Beijing Tide Pharmaceutical

Morepen Laboratories

Metrochem API

Hema Pharmaceuticals

Frosst Iberica SA

Atom Pharma

Etoricoxib Segment by Type

120 mg

30 mg

60 mg

90 mg

Etoricoxib Segment by Application

Hospital

Pharmacy

Others

Etoricoxib Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etoricoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etoricoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etoricoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Etoricoxib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Etoricoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Etoricoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Etoricoxib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Etoricoxib Industry Trends Table 2. Etoricoxib Industry Drivers Table 3. Etoricoxib Industry Opportunities and Challenges Table 4. Etoricoxib Industry Restraints Table 5. Global Etoricoxib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Etoricoxib Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Etoricoxib Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Etoricoxib Sales Market Share by Manufacturers Table 9. Global Etoricoxib Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Etoricoxib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Etoricoxib Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Etoricoxib Manufacturers, Product Type & Application Table 13. Global Etoricoxib Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Etoricoxib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 120 mg Table 17. Major Manufacturers of 30 mg Table 18. Major Manufacturers of 60 mg Table 19. Major Manufacturers of 90 mg Table 20. Global Etoricoxib Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Etoricoxib Sales by Type (2021-2026) & (K Units) Table 22. Global Etoricoxib Sales by Type (2027-2032) & (K Units) Table 23. Global Etoricoxib Sales Market Share by Type (2021-2026) Table 24. Global Etoricoxib Sales Market Share by Type (2027-2032) Table 25. Global Etoricoxib Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Etoricoxib Revenue by Type (2021-2026) & (K Units) Table 27. Global Etoricoxib Revenue by Type (2027-2032) & (K Units) Table 28. Global Etoricoxib Revenue Market Share by Type (2021-2026) Table 29. Global Etoricoxib Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Pharmacy Table 32. Major Manufacturers of Others Table 33. Global Etoricoxib Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Etoricoxib Sales by Application (2021-2026) & (K Units) Table 35. Global Etoricoxib Sales by Application (2027-2032) & (K Units) Table 36. Global Etoricoxib Sales Market Share by Application (2021-2026) Table 37. Global Etoricoxib Sales Market Share by Application (2027-2032) Table 38. Global Etoricoxib Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Etoricoxib Revenue by Application (2021-2026) & (K Units) Table 40. Global Etoricoxib Revenue by Application (2027-2032) & (K Units) Table 41. Global Etoricoxib Revenue Market Share by Application (2021-2026) Table 42. Global Etoricoxib Revenue Market Share by Application (2027-2032) Table 43. Global Etoricoxib Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Etoricoxib Sales by Region (2021-2026) & (K Units) Table 45. Global Etoricoxib Sales Market Share by Region (2021-2026) Table 46. Global Etoricoxib Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Etoricoxib Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Etoricoxib Sales by Country (2021-2026) & (K Units) Table 50. North America Etoricoxib Sales by Country (2027-2032) & (K Units) Table 51. Europe Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Etoricoxib Sales by Country (2021-2026) & (K Units) Table 53. Europe Etoricoxib Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Etoricoxib Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Etoricoxib Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Etoricoxib Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Etoricoxib Sales by Country (2027-2032) & (K Units) Table 60. Global Etoricoxib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Etoricoxib Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Etoricoxib Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Etoricoxib Revenue Market Share by Region (2021-2026) Table 64. Global Etoricoxib Revenue Market Share by Region (2027-2032) Table 65. Shanghai Shyndec Pharmaceutical Company Information Table 66. Shanghai Shyndec Pharmaceutical Business Overview Table 67. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolio Table 69. Shanghai Shyndec Pharmaceutical Recent Development Table 70. Qilu Pharmaceutical Company Information Table 71. Qilu Pharmaceutical Business Overview Table 72. Qilu Pharmaceutical Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Qilu Pharmaceutical Etoricoxib Product Portfolio Table 74. Qilu Pharmaceutical Recent Development Table 75. Merck & Co Company Information Table 76. Merck & Co Business Overview Table 77. Merck & Co Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck & Co Etoricoxib Product Portfolio Table 79. Merck & Co Recent Development Table 80. Easton Biopharmaceuticals Company Information Table 81. Easton Biopharmaceuticals Business Overview Table 82. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Easton Biopharmaceuticals Etoricoxib Product Portfolio Table 84. Easton Biopharmaceuticals Recent Development Table 85. Beijing Tide Pharmaceutical Company Information Table 86. Beijing Tide Pharmaceutical Business Overview Table 87. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Beijing Tide Pharmaceutical Etoricoxib Product Portfolio Table 89. Beijing Tide Pharmaceutical Recent Development Table 90. Morepen Laboratories Company Information Table 91. Morepen Laboratories Business Overview Table 92. Morepen Laboratories Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Morepen Laboratories Etoricoxib Product Portfolio Table 94. Morepen Laboratories Recent Development Table 95. Metrochem API Company Information Table 96. Metrochem API Business Overview Table 97. Metrochem API Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Metrochem API Etoricoxib Product Portfolio Table 99. Metrochem API Recent Development Table 100. Hema Pharmaceuticals Company Information Table 101. Hema Pharmaceuticals Business Overview Table 102. Hema Pharmaceuticals Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Hema Pharmaceuticals Etoricoxib Product Portfolio Table 104. Hema Pharmaceuticals Recent Development Table 105. Frosst Iberica SA Company Information Table 106. Frosst Iberica SA Business Overview Table 107. Frosst Iberica SA Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Frosst Iberica SA Etoricoxib Product Portfolio Table 109. Frosst Iberica SA Recent Development Table 110. Atom Pharma Company Information Table 111. Atom Pharma Business Overview Table 112. Atom Pharma Etoricoxib Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Atom Pharma Etoricoxib Product Portfolio Table 114. Atom Pharma Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Etoricoxib Distributors List Table 118. Etoricoxib Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Etoricoxib Product Image Figure 2. Global Etoricoxib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etoricoxib Market Size (2021-2032) & (US$ Million) Figure 4. Global Etoricoxib Sales (2021-2032) & (K Units) Figure 5. Global Etoricoxib Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Etoricoxib Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 120 mg Image Figure 9. 30 mg Image Figure 10. 60 mg Image Figure 11. 90 mg Image Figure 12. Global Etoricoxib Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Etoricoxib Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Etoricoxib Sales Market Share by Type (2021-2032) Figure 15. Global Etoricoxib Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Etoricoxib Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Etoricoxib Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Others Image Figure 21. Global Etoricoxib Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Etoricoxib Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Etoricoxib Sales Market Share by Application (2021-2032) Figure 24. Global Etoricoxib Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Etoricoxib Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Etoricoxib Revenue Market Share by Application (2021-2032) Figure 27. North America Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Etoricoxib Sales Market Share by Country (2021-2032) Figure 29. U.S. Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Etoricoxib Sales Market Share by Country (2021-2032) Figure 34. Germany Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Etoricoxib Sales Market Share by Country (2021-2032) Figure 41. China Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Etoricoxib Sales Market Share by Country (2021-2032) Figure 49. Brazil Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Etoricoxib Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Etoricoxib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Etoricoxib Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Etoricoxib Revenue (2021-2032) & (US$ Million) Figure 60. North America Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Etoricoxib Revenue (2021-2032) & (US$ Million) Figure 62. Europe Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Etoricoxib Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Etoricoxib Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Etoricoxib Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Etoricoxib Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 120 mg
  • 30 mg
  • 60 mg
  • 90 mg
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Shanghai Shyndec Pharmaceutical
  • Qilu Pharmaceutical
  • Merck & Co
  • Easton Biopharmaceuticals
  • Beijing Tide Pharmaceutical
  • Morepen Laboratories
  • Metrochem API
  • Hema Pharmaceuticals
  • Frosst Iberica SA
  • Atom Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Etoricoxib Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Etoricoxib Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Etoricoxib Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Etoricoxib Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Etoricoxib Market Dynamics
  1. 2.1 Etoricoxib Industry Trends
  2. 2.2 Etoricoxib Industry Drivers
  3. 2.3 Etoricoxib Industry Opportunities and Challenges
  4. 2.4 Etoricoxib Industry Restraints
3 Etoricoxib Market by Manufacturers
  1. 3.1 Global Etoricoxib Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Etoricoxib Sales by Manufacturers (2021-2026)
  3. 3.3 Global Etoricoxib Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Etoricoxib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Etoricoxib Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Etoricoxib Manufacturers, Product Type & Application
  7. 3.7 Global Etoricoxib Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Etoricoxib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Etoricoxib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Etoricoxib Tier 1, Tier 2, and Tier 3
4 Etoricoxib Market by Type
  1. 4.1 Etoricoxib Type Introduction
  2. 4.1.1 120 mg
  3. 4.1.2 30 mg
  4. 4.1.3 60 mg
  5. 4.1.4 90 mg
  6. 4.2 Global Etoricoxib Sales by Type
  7. 4.2.1 Global Etoricoxib Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Etoricoxib Sales by Type (2021-2032)
  9. 4.2.3 Global Etoricoxib Sales Market Share by Type (2021-2032)
  10. 4.3 Global Etoricoxib Revenue by Type
  11. 4.3.1 Global Etoricoxib Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Etoricoxib Revenue by Type (2021-2032)
  13. 4.3.3 Global Etoricoxib Revenue Market Share by Type (2021-2032)
5 Etoricoxib Market by Application
  1. 5.1 Etoricoxib Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Etoricoxib Sales by Application
  6. 5.2.1 Global Etoricoxib Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Etoricoxib Sales by Application (2021-2032)
  8. 5.2.3 Global Etoricoxib Sales Market Share by Application (2021-2032)
  9. 5.3 Global Etoricoxib Revenue by Application
  10. 5.3.1 Global Etoricoxib Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Etoricoxib Revenue by Application (2021-2032)
  12. 5.3.3 Global Etoricoxib Revenue Market Share by Application (2021-2032)
6 Global Etoricoxib Sales by Region
  1. 6.1 Global Etoricoxib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Etoricoxib Sales by Region (2021-2032)
  3. 6.2.1 Global Etoricoxib Sales by Region (2021-2026)
  4. 6.2.2 Global Etoricoxib Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Etoricoxib Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Etoricoxib Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Etoricoxib Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Etoricoxib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Etoricoxib Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Etoricoxib Revenue by Region
  1. 7.1 Global Etoricoxib Revenue by Region
  2. 7.1.1 Global Etoricoxib Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Etoricoxib Revenue by Region (2021-2026)
  4. 7.1.3 Global Etoricoxib Revenue by Region (2027-2032)
  5. 7.1.4 Global Etoricoxib Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Etoricoxib Revenue (2021-2032)
  8. 7.2.2 North America Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Etoricoxib Revenue (2021-2032)
  11. 7.3.2 Europe Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Etoricoxib Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Etoricoxib Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Etoricoxib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Shyndec Pharmaceutical
  2. 8.1.1 Shanghai Shyndec Pharmaceutical Company Information
  3. 8.1.2 Shanghai Shyndec Pharmaceutical Business Overview
  4. 8.1.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolio
  6. 8.1.5 Shanghai Shyndec Pharmaceutical Recent Developments
  7. 8.2 Qilu Pharmaceutical
  8. 8.2.1 Qilu Pharmaceutical Company Information
  9. 8.2.2 Qilu Pharmaceutical Business Overview
  10. 8.2.3 Qilu Pharmaceutical Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Pharmaceutical Etoricoxib Product Portfolio
  12. 8.2.5 Qilu Pharmaceutical Recent Developments
  13. 8.3 Merck & Co
  14. 8.3.1 Merck & Co Company Information
  15. 8.3.2 Merck & Co Business Overview
  16. 8.3.3 Merck & Co Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co Etoricoxib Product Portfolio
  18. 8.3.5 Merck & Co Recent Developments
  19. 8.4 Easton Biopharmaceuticals
  20. 8.4.1 Easton Biopharmaceuticals Company Information
  21. 8.4.2 Easton Biopharmaceuticals Business Overview
  22. 8.4.3 Easton Biopharmaceuticals Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Easton Biopharmaceuticals Etoricoxib Product Portfolio
  24. 8.4.5 Easton Biopharmaceuticals Recent Developments
  25. 8.5 Beijing Tide Pharmaceutical
  26. 8.5.1 Beijing Tide Pharmaceutical Company Information
  27. 8.5.2 Beijing Tide Pharmaceutical Business Overview
  28. 8.5.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Tide Pharmaceutical Etoricoxib Product Portfolio
  30. 8.5.5 Beijing Tide Pharmaceutical Recent Developments
  31. 8.6 Morepen Laboratories
  32. 8.6.1 Morepen Laboratories Company Information
  33. 8.6.2 Morepen Laboratories Business Overview
  34. 8.6.3 Morepen Laboratories Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Morepen Laboratories Etoricoxib Product Portfolio
  36. 8.6.5 Morepen Laboratories Recent Developments
  37. 8.7 Metrochem API
  38. 8.7.1 Metrochem API Company Information
  39. 8.7.2 Metrochem API Business Overview
  40. 8.7.3 Metrochem API Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Metrochem API Etoricoxib Product Portfolio
  42. 8.7.5 Metrochem API Recent Developments
  43. 8.8 Hema Pharmaceuticals
  44. 8.8.1 Hema Pharmaceuticals Company Information
  45. 8.8.2 Hema Pharmaceuticals Business Overview
  46. 8.8.3 Hema Pharmaceuticals Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hema Pharmaceuticals Etoricoxib Product Portfolio
  48. 8.8.5 Hema Pharmaceuticals Recent Developments
  49. 8.9 Frosst Iberica SA
  50. 8.9.1 Frosst Iberica SA Company Information
  51. 8.9.2 Frosst Iberica SA Business Overview
  52. 8.9.3 Frosst Iberica SA Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Frosst Iberica SA Etoricoxib Product Portfolio
  54. 8.9.5 Frosst Iberica SA Recent Developments
  55. 8.10 Atom Pharma
  56. 8.10.1 Atom Pharma Company Information
  57. 8.10.2 Atom Pharma Business Overview
  58. 8.10.3 Atom Pharma Etoricoxib Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Atom Pharma Etoricoxib Product Portfolio
  60. 8.10.5 Atom Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Etoricoxib Value Chain Analysis
  2. 9.1.1 Etoricoxib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Etoricoxib Production Mode & Process
  6. 9.2 Etoricoxib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Etoricoxib Distributors
  9. 9.2.3 Etoricoxib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst